TET2 and pulmonary arterial hypertension: Females accounted for 70% of each group, and the mean ± SEM ages in the PAH, PAH with TET2 mutation, and control groups were 71.6 ± 8.1, 69.1 ± 10.7, and 75.5 ± 6.7 years, respectively.